5 years ago

uMotif Secures £5 Million Series A to Expand Patient-Centric Clinical Research Platform

  • uMotif, a London-based patient-centric data capture software company, has raised £5 million in a Series A funding round led by AlbionVC

  • The funding will be used to accelerate uMotif's growth, further develop its platform, and expand into new study types and territories

  • uMotif's technology enables decentralized and virtual study designs, allowing patients to participate in studies from their own devices

  • The company's platform is designed to increase patient engagement, improve data quality, and reduce the burden on participants

  • The funding round also saw participation from Oslo-based DNV-GL and existing angel investors.

      • ProblemHealthcare

      "Recruiting and retaining patients for clinical trials is expensive and time-consuming, often leading to delays in getting new therapies to patients."

      Solution

      "uMotif provides a patient-centric data capture platform that makes it easier for patients to participate in clinical trials from anywhere, using their own devices. This leads to higher engagement, better data quality, and faster drug development."

      Covered on